Azithromycin Powder for oral solution 200 mg/5ml
Product Description
Srs Life Sciences Pte. Ltd.
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
Srs Life Sciences Pte. Ltd.
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
More Products from Srs Life Sciences Pte. Ltd. (16)
-
Product Ertugliflozin and combination Tablets
Ertugliflozin tablets, marketed under the brand names STEGLATRO, STEGLUJAN, and SEGLUROMET, is still under development. -
Product L-Glutamine oral powder
Rare disease product
Developed in India, a generic version of Endari approved in US
Dossier ready for emerging Markets
Will undergo clinical Trials for sickle cell in Q3 2026 -
Product Spherical Carbon Adsorbent in fine granules
Meets the Japan RLD Kremezin granules, worldwide charcoal tablets are already available. The carbon in granule form is more easy to use
Dossier Readiness Q4 2026 -
Product Suxibuzone and Suxibuzone sachet
Suxibuzone is an analgesic used for joint and muscular pain. It is a prodrug of the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone, -
Product Sevelamer Carbonate powder for oral suspension 0.8g, 2.4g
RLD is Renvela (Genzyme). It is open for outlicensing for EU, Canada, Australia and Emerging countries. -
Product Sevelamer Carbonate Tablets 400mg, 800mg
RLD is Renvela (Genzyme). It is open for outlicensing for EU, Canada, Australia and Emerging countries. -
Product Lamotrigine Oral suspension
RLD: Subvenite US
Tech Transfer Readiness- Q3 2027
Dossier Readiness Q2 2028 -
Product Resmitrom Tablets
RLD: Rezdiffra
Tech Transfer readiness- Q4 2027 -
Product Risdiplam Powder for Oral solution
RLD: Evrsdi,
API -under development
FDF- Tech Transfer Readiness- Q3 2027
Dossier Readiness- Q3 2028 -
Product Canagliflozin Tablets
Meets the RLD EU, US InvoKana, Ready for tech transfer, Dossier readiness Q2 2027 -
Product Lacosamide ER Capsule
RLD : Motpply XR US
Tech Transfer Readiness- Q2 2027 -
Product Cariprazine Capsules
Under development, The RLD used is Vraylar, Tech transfer readiness Q4 2026, Dossier readiness Q3 2027
Srs Life Sciences Pte. Ltd. resources (1)
-
Video SRS Life Sciences Pte Ltd at CPHI Worldwide 2018
Rajah Dubey, Chief Technical Strategist of SRS Life Sciences, speaks with CPHI TV at CPHI Worldwide in Madrid.